Playback speed
10 seconds
ESMO 2024 Insights: Pembro + CAPOX + Bevacizumab in MSS mCRC With High Immune Infiltrate - FFCD 1703 POCHI Trial
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
David Tougeron
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
David Tougeron
0 views
September 27, 2024
Login to view comments.
Click here to Login